Back to the main directory
EarningsReview / Equity
- Factoring in higher iron ore; multiple compression remains by BNP Paribas Exane
- Dolphin Drilling (Buy, TP: NOK15.00) - De-risked and building scale by DnB Markets
- The weekly navigator by DnB Markets
- Bakkavor (BAKK LN) by HSBC
- More NII upside to come, even when rates normalise by BNP Paribas Exane
- Yielding a result by BNP Paribas Exane
- Postcard from the West Coast: Feedback from one on one company meetings with MSFT, CRM, NOW and SHOP by BNP Paribas Exane
- INVEST SECURITIES – AFFLUENT MEDICAL : Clinique robuste et réorientation sur les US - ACHAT, OC 3,3€ vs 4,0€ by Invest Securities
- Italian Wine Brands S.p.A. - H1 2023 – Diversification by MidCap Partners
- Orders accelerate when PandL shows solid positive trends in Q1 by BNP Paribas Exane
- FQ3''23 postview: Adoption now, monetisation later by BNP Paribas Exane
- Business normalization and cost inflation on the cards by BNP Paribas Exane
- Weekly prescription tracker by BNP Paribas Exane
- 杰克股份（603337 CH） by HSBC
- Macro, Valuation, Exposures, Sensitivities and Performance Sheets by BNP Paribas Exane
- A+B=C: FY25e dollar EBIT targets reiterated by BNP Paribas Exane
- ReNeuron Group - A step forward on the Exosome delivery platform by Edison Investment Research
- China Insurance by HSBC
- WestRock acquisition: your questions, our answers by BNP Paribas Exane
- Pre-Close Call Feedback (3Q23) by BNP Paribas Exane
- Sustainability Weekly 11 – 15 Septembre 2023 by Oddo BHF
- Strike Whac-A-Mole: Our Dynamic UAW Analysis by BNP Paribas Exane
- Phoenix Group (PHNX LN) by HSBC
- by BNP Paribas Exane
- KEFI Gold and Copper - East Africa and Ethiopia attracting investment by Edison Investment Research